Atlas Trials

A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Clinical trial NCT00380796 · COMPLETED

Trial details

NCT number
NCT00380796
Sponsor
Centocor, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
COPDPulmonary Disease, Chronic Obstructive
Start date
2006-04-01
Primary completion
2009-12-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.